These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2407090)

  • 1. Clinical pharmacokinetics of moricizine.
    Siddoway LA; Schwartz SL; Barbey JT; Woosley RL
    Am J Cardiol; 1990 Feb; 65(8):21D-25D; discussion 68D-71D. PubMed ID: 2407090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of moricizine HCl.
    Woosley RL; Morganroth J; Fogoros RN; McMahon FG; Humphries JO; Mason DT; Williams RL
    Am J Cardiol; 1987 Oct; 60(11):35F-39F. PubMed ID: 3310583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class IB antiarrhythmic drugs: tocainide, mexiletine, and moricizine.
    Snyder DW
    J La State Med Soc; 1989 May; 141(5):21-5. PubMed ID: 2499645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic drug therapy for congestive heart failure with focus on moricizine.
    Podrid PJ; Beau SL
    Am J Cardiol; 1990 Feb; 65(8):56D-64D; discussion 68D-71D. PubMed ID: 2407092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug interactions with Ethmozine (moricizine HCl).
    Kennedy HL; Wood AJ; MacFarland RT
    Am J Cardiol; 1987 Oct; 60(11):79F-82F. PubMed ID: 3310590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moricizine: a novel antiarrhythmic agent.
    Carnes CA; Coyle JD
    DICP; 1990; 24(7-8):745-53. PubMed ID: 2197817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moricizine. A review of its pharmacological properties, and therapeutic efficacy in cardiac arrhythmias.
    Fitton A; Buckley MT
    Drugs; 1990 Jul; 40(1):138-67. PubMed ID: 2202581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moricizine: a new class I antiarrhythmic.
    Mann HJ
    Clin Pharm; 1990 Nov; 9(11):842-52. PubMed ID: 2272151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias.
    Anderson JL
    Am J Cardiol; 1990 Feb; 65(8):32D-40D. PubMed ID: 2106254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic efficacy of Ethmozine (moricizine HCl) compared with disopyramide and propranolol.
    Pratt CM; Butman SM; Young JB; Knoll M; English LD
    Am J Cardiol; 1987 Oct; 60(11):52F-58F. PubMed ID: 3310586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum digoxin concentrations during ethmozine antiarrhythmic therapy.
    Kennedy HL; Sprague MK; Redd RM; Wiens RD; Blum RI; Buckingham TA
    Am Heart J; 1986 Apr; 111(4):667-72. PubMed ID: 2420164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose effect of moricizine on suppression of ventricular arrhythmias.
    Morganroth J
    Am J Cardiol; 1990 Feb; 65(8):26D-31D; discussion 68D-71D. PubMed ID: 1689534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, safety, hemodynamic effects, and pharmacokinetics of high-dose moricizine during short- and long-term therapy.
    Salerno DM; Sharkey PJ; Granrud GA; Asinger RW; Hodges M
    Clin Pharmacol Ther; 1987 Aug; 42(2):201-9. PubMed ID: 3301153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerance of Ethmozine (moricizine HCl) in placebo-controlled trials.
    Morganroth J; Pratt CM; Kennedy HL; Singh SN; Platt ML; Baker BJ; Mason DT
    Am J Cardiol; 1987 Oct; 60(11):48F-51F. PubMed ID: 3310585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac electrophysiologic effects of moricizine hydrochloride.
    Bigger JT
    Am J Cardiol; 1990 Feb; 65(8):15D-20D; discussion 68D-71D. PubMed ID: 2407089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of moricizine on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
    Benedek IH; King SY; Powell RJ; Agra AM; Schary WL; Pieniaszek HJ
    J Clin Pharmacol; 1992 Jun; 32(6):558-63. PubMed ID: 1634644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placement of moricizine in the selection of antiarrhythmic drug therapy.
    Morganroth J
    Am J Cardiol; 1990 Feb; 65(8):65D-67D; discussion 68D-71D. PubMed ID: 2407093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethmozine (moricizine HCl) therapy for complex ventricular arrhythmias.
    Hession MJ; Lampert S; Podrid PJ; Lown B
    Am J Cardiol; 1987 Oct; 60(11):59F-66F. PubMed ID: 3310587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Ethmozine (moricizine HCl) on ventricular function using echocardiographic, hemodynamic and radionuclide assessments.
    Pratt CM; Podrid PJ; Seals AA; Young JB; Hession M; Lampert S; Quiñones M; Lown B
    Am J Cardiol; 1987 Oct; 60(11):73F-78F. PubMed ID: 3310589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical development of moricizine as an antiarrhythmic agent.
    Mahler SA; Borland RM
    Am J Cardiol; 1990 Feb; 65(8):11D-14D; discussion 68D-71D. PubMed ID: 2407088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.